This resource is no longer available

During the drug development process, pharmaceutical companies generate vast amounts of data, all of which must be analyzed.

Enter cloud-based high-performance computing (HPC), positioned to speed up drug discovery

So, how can pharmaceutical companies leverage HPC built for the cloud? For an introduction to a HPC cloud platform that runs virtualized on AWS powered on NVIDIA, read this white paper.

Rescale needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, please review our Privacy Policy.

Vendor:

AWS, NVIDIA & RESCALE

Posted:

Sep 21, 2023

Published:

Sep 21, 2023

Format:

PDF

Type:

White Paper